论文部分内容阅读
糠尿病人适当血压控制(ABCD)试验的暂时结果解释了为什么长效钙拮抗剂尼索地平(nisoldipine)不能用于伴有型糖尿病的高血压患者。尼索地平是去年被安全监测委员会推荐使用的。由于意外发现应用尼索地平的高血压患者发生心梗的人数是应用血管紧张素转化酶抑制剂(ACEI)治疗的5倍,
The provisional results of the appropriate blood pressure control (ABCD) trial of the glycosuria patient explain why the long-acting calcium antagonist nisoldipine can not be used in hypertensive patients with diabetes mellitus. Nisoldipine was recommended by the safety monitoring committee last year. Since it was unexpectedly found that the number of myocardial infarctions in hypertensive patients receiving nisoldipine was 5-fold greater than those treated with angiotensin-converting enzyme inhibitor (ACEI)